https://clinicaltrials.gov/ct2/show/NCT03713957?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F08%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson’s Disease and Cognitive Impairment
DESCRIPTION:
Condition: Parkinson Disease
Interventions: Drug: GRF6021; Other: Placebo
Sponsors: Alkahest, Inc.; Michael J. Fox Foundation for Parkinson’s Research
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03713957
FIRST POSTED:
Mon, 22 Oct 2018 12:00:00 EDT
LAST UPDATE POSTED:
05/22/19 07:42AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03713957?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F08%2F2019&lupd_d=14&sort=nwst